This content is current only at the time of printing. This document was printed on 9 December 2019. A current copy is located at https://apvma.gov.au/node/20181
You are here
Vet drug approved in first ever trilateral joint review
A new use for the veterinary drug Metacam has been approved in the first ever trilateral joint review for a veterinary drug.
Castration of male sheep is common practice in the sheep industry. The pain and stress this can cause can now be relieved by the non-steroidal anti-inflammatory drug—Metacam. It has been approved for single dose use in sheep and lambs 14 days of age or older for the alleviation of pain and inflammation.
To achieve this outcome, efficacy, target animal safety and human food safety were jointly reviewed by the three regulatory bodies, as part of the trilateral joint review.
Health Canada, the Australian Pesticides and Veterinary Medicines Authority and the New Zealand Ministry for Primary Industries approved the use of Metacam on 28 April 2016. This collaboration will provide numerous benefits and efficiencies such as simultaneous access to a new veterinary medicine in three major markets leading to improved animal health and food safety.